Appointment of Chief Financial Officer w.e.f. 01.07.2025

Management Changes View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+2.5%Reaction day

₹43.25

prior close

—

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.1%+2.5% vs market

Commodity Chemicals peers, median of 53sector+0.5%+2.0% vs sector

On the reaction day the stock moved 2.5 pts more than Nifty Microcap 250 and 2.0 pts more than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+2.5+0.1+2.5+0.5+2.0

Next day

+0.1-0.1+0.2+0.1+0.0

+2.5-0.0+2.6+0.5+2.1

+2.3+0.4+1.9+0.3+2.0

-1.7-0.1-1.6-0.6-1.2

-0.6-0.2-0.3-0.6+0.1

-2.1+0.6-2.8-0.2-2.0

15d

+7.2+1.5+5.7-0.1+7.3

+6.4-2.7+9.0-3.5+9.9

+5.8-3.8+9.5-4.9+10.7

+8.7-4.1+12.8-5.4+14.1

UpDownMarket · Nifty Microcap 250Sector · Commodity Chemicals peers, median of 53Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Archit Organosys Ltd has announced the appointment of a new Chief Financial Officer (CFO), with the role taking effect from July 1, 2025. The CFO is a Key Managerial Personnel (KMP) under company law, and this appointment is part of the company's leadership restructuring. No further details about the incoming CFO's name or background have been provided in this filing. The change is a routine corporate governance update, with the company formally disclosing the appointment to the stock exchange.

Likely market impact

A new CFO appointment is a routine leadership change and is not expected to materially impact the stock price in the short term. Shareholders should watch for further details on the appointee's background and any strategic direction changes that may follow.